AI Hunt for ALS Treatment Continues With 28 Novel Targets Revealed by Insilico Medicine

Insilico Medicine identified 28 new targets for the treatment of amyotrophic lateral sclerosis (ALS) using its proprietary AI-driven platform PandaOmics. …

Continue ›››

The Aging Research Is On The Rise

It took more than eight decades since the landmark experiments on calorie restrictions in 1930th to get to a point …

Continue ›››

Paradigm4 Brings Single Cell Community Closer to Custom-Made Cell Atlas

Paradigm4 just launched an integral component of the REVEAL: Single Cell - a Precision Cell AtlasTM, which enables researchers to …

Continue ›››

In the Largest Study, AI Found To Increase Efficiency of Breast Cancer Screening -- When Combined with Human Intelligence

Today, German artificial intelligence (AI) startup Vara published peer-reviewed research in Lancet Digital Health highlighting how a combination of AI …

Continue ›››

How Data-sharing Technologies Bolster AI Progress in Medical Research

While artificial intelligence (AI) already proved to be a groundbreaking thing in many industries (robotics, finance, surveillance, cyber security, self-driving …

Continue ›››

Owkin Announces First-ever Large-scale Use of AI to Enhance Clinical Trials

A French-American healthcare unicorn Owkin, which applies artificial intelligence (AI) and federated learning frameworks to drug discovery, has just announced …

Continue ›››

The First Innovation in Treatment of Low Testosterone in Men Since 1930th

Acesis Biomed, a biotechnology company based in the US and the UK, is developing an innovative solution for the treatment …

Continue ›››

Insilico Medicine Snaps Up $60M to Create Robotic Lab of the Future

Hong Kong-based pioneer of the artificial intelligence (AI)-driven drug discovery, a clinical stage biotech Insilico Medicine, has completed a $60 …

Continue ›››

Professor Sidney Altman

Because of the war I’ve missed the news about the death of Sidney Altman on April 5, 2022. Altman is …

Continue ›››

Tissue Selective E3 Ligase-based Degraders

The efficacy and selectivity of protein degrader drugs depend on their affinity to the target protein but also on the type …

Continue ›››

Virtual Reality in Drug Discovery: More Useful Than You Probably Think

Using virtual reality (VR) for manipulating 3D models of small molecules and large biomolecules in the context of drug design …

Continue ›››

Bioengineered Extracellular Vesicles - Potential Boon for Delivering Biotherapeutics

Because of endogenous properties, extracellular vesicles (EVs) have shown impressive potential as remedial modalities; nevertheless, more bioengineering refinement is expected …

Continue ›››